Share the post "ANG Lifesciences India announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -67.39 % over the year, decrease in net sales/revenue by -51.35 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 306.65 %. Marginal increase in other income during this quarter, up by 183.06%.
- Profit over the Year and quarter: Challenges in sustaining profitability for ANG Lifesciences India Limited. Profit dropped by -275.4 % Year to Year, ANG Lifesciences India Limited’s profitability dropped by -15.74 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -266.67 % Year to Year. EPS decreased by -14.55 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 56.462 Cr | Rs. 37.84 Cr | Rs. 18.41 Cr | -51.35 % | -67.39 % |
| Expenses | Rs. 49.92 Cr | Rs. 34.48 Cr | Rs. 20.12 Cr | -41.65 % | -59.7 % |
| Operating Profit | Rs. 6.54 Cr | Rs. 3.36 Cr | Rs. -1.71 Cr | -150.89 % | -126.15 % |
| OPM % | 11.58 % | 8.88 % | -9.29 % | -18.17 % | -20.87 % |
| Other Income | Rs. 0.316 Cr | Rs. -1.547 Cr | Rs. 1.285 Cr | + 183.06 % | + 306.65 % |
| Interest | Rs. 2.31 Cr | Rs. 3.84 Cr | Rs. 2.08 Cr | -45.83 % | -9.96 % |
| Depreciation | Rs. 2.19 Cr | Rs. 2.05 Cr | Rs. 1.63 Cr | -20.49 % | -25.57 % |
| Profit before tax | Rs. 2.36 Cr | Rs. -4.08 Cr | Rs. -4.14 Cr | -1.47 % | -275.42 % |
| Tax % | 25.79 % | -10.53 % | -25.79 % | -15.26 % | -51.58 % |
| Net Profit | Rs. 1.75 Cr | Rs. -3.65 Cr | Rs. -3.07 Cr | + 15.89 % | -275.43 % |
| EPS in Rs | Rs. 1.41 | Rs. -2.75 | Rs. -2.35 | + 14.55 % | -266.67 % |
Today, we’re looking at ANG Lifesciences India Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -67.39 %. However, it did see a marginal slip of -51.35 % from the previous quarter. Expenses decreased slightly by -41.65 % quarter-on-quarter, aligning with the annual decline of -59.7 %. Operating profit, while down -126.15 % compared to last year, faced a quarter-on-quarter dip of -150.89 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -20.87 %, but a shrinkage of -18.17 % sequentially. Other income rose by 183.06 % compared to the last quarter, despite an annual growth of 306.65 %. Interest expenses dropped significantly by -45.83 % from the previous quarter, yet the year-over-year decrease remains at a moderate -9.96 %. Depreciation costs fell by -20.49 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -25.57 %. Profit before tax declined annually by -275.42 % but saw a reduction from the preceding quarter by -1.47 %.
Tax expenses as a percentage of profits decreased slightly by -51.58 % compared to last year, with a more notable quarter-on-quarter decrease of -15.26 %. Net profit fell by -275.43 % year-on-year but experienced a 15.89 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -266.67 % but a quarterly rise of 14.55 %. In summary, ANG Lifesciences India Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 56.462 Cr | Rs. 37.84 Cr | Rs. 18.41 Cr | -51.35 % | -67.39 % |
| Expenses | Rs. 49.92 Cr | Rs. 34.48 Cr | Rs. 20.12 Cr | -41.65 % | -59.7 % |
| Operating Profit | Rs. 6.54 Cr | Rs. 3.36 Cr | Rs. -1.71 Cr | -150.89 % | -126.15 % |
| Net Profit | Rs. 1.75 Cr | Rs. -3.65 Cr | Rs. -3.07 Cr | + 15.89 % | -275.43 % |
| EPS in Rs | Rs. 1.41 | Rs. -2.75 | Rs. -2.35 | + 14.55 % | -266.67 % |
In reviewing ANG Lifesciences India Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -67.39 % year-on-year, although there was a slight dip of -51.35 % from the previous quarter. Expenses decreased by -59.7 % compared to the previous year, with a decrease of -41.65 % quarter-on-quarter. Operating Profit dropped by -126.15 % annually, and saw a -150.89 % decrease from the last quarter.
Net Profit showed yearly decrease of -275.43 %, and experienced a 15.89 % increase from the previous quarter. Earnings Per Share (EPS) fell by -266.67 % annually, however rose by 14.55 % compared to the last quarter. In essence, while ANG Lifesciences India Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”ANG Lifesciences India “]
